Glycomics Market: Current Analysis and Forecast (2021-2027)

$3500$6860

Emphasis on Product (Enzymes, Instruments, Kits, Reagents, Others); Application (Diagnostics, Drug Discovery & Development, Others); End-User (Pharmaceutical & Biotechnology Companies, Clinical Laboratories, Academic Research Institutes, Others); Region and Country

Pages:

152

Table:

72

Figure:

114

Report ID:

UMHE21325

Geography:

Clear
  Get a Free Sample
SKU: UMHE21325 Category:
Report Description
Table of content
Research Methodology

Report Description

Global Glycomics Market was valued at US$ XX billion in 2020 and is anticipated to reach US$ XX billion by 2027 displaying an elevated CAGR of XX% over the forecast period (2021-2027). Glycomics is a subset of the glycobiology field that deals in identifying the structure and function of the complete set of the glycome produced in a particular cell or organism and identify all the genes that encode glycoproteins. It is one of the rapidly emerging research fields highlighting functional aspects of glycans in biological systems.

The glycomics market is growing exponentially on account of growth in mortality rates and incidences of cancer and other chronic diseases coupled with the heavy demand for medicines across the world. For instance, according to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 9.6 million deaths in 2018. this number has been increased and has reached around 10 million deaths globally in 2020. therefore, scientists across the world are carrying out high-level research on cancer therapeutics and diagnostics including research on glycomic biomarkers as many recent studies suggest that glycan structure correlates with cancer development

With rapid technological advancement and rising investment in research & development of pharmaceutical & biotechnology companies, the glycomics market is witnessing an uptick all over the globe. For instance, The Pharmaceutical Research and Manufacturers of America (PhRMA) trade group represents the leading biopharmaceutical research companies in the United States. In 2019, the research and development (R&D) expenditure of its member companies reached USD 83 billion worldwide, up from USD 79.6 billion in 2018. Furthermore, the growing focus on Glycomics research owing to its wide scope of applications in drug discovery and development and other varied segments is propelling the growth of this market

Current & Projected Total Global Spending on Pharmaceutical R&D, 2016-2026 (in USD billion) 

Thermo Fisher Scientific, Agilent Technologies, Danaher, Merck KGaA, RayBiotech, Shimadzu Corporation, Takara Bio, New England Biolabs, S-BIO, Waters Corporation are some of the prominent players operating in the global glycomics market. Several M&A’s along with partnerships have been undertaken by these players to develop new and advanced Glycomics tools.

Insights Presented in the Report

“Amongst product, enzymes segment holds the major share”

Based on product, the market is fragmented into Enzymes, Instruments, Kits, Reagents, and Others. The enzymes segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F as enzymes are the proteins in the drug design that act as drug targets for various diseases in the process of drug discovery and development. In addition to this, the growth of this segment is also attributed to the wide scope of applications of enzymes in research related to cancer & diagnostics. The enzymes segment is also further sub-segmented into Glycosidases, Glycosyltransferases, Neuraminidases, Sialyltransferases, and others. Amongst these enzymes, glycosidases acquired the major market share owing to their use in oncology research.

“Amongst application, drug discovery & development is anticipated to grow at the highest CAGR during the analyzed period”

Based on application, the market is fragmented into diagnostics, drug discovery and development, and others. The drug discovery & development segment generated revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX  million by 2027F owing to the rising potential of glycomics in the identification of biomarkers and increase in demand for glycomics products in drug discovery & development as glycan chains can be modified to synthesize various drugs. For example, a naturally occurring disaccharide unit of glycosaminoglycan known as hyaluronan has wide applications in medicine as it is used in post-surgical wounds.

Amongst end-user, academic research institutes segment holds the major share”

Based on end-users, the market is fragmented into pharmaceutical & biotechnology companies, clinical laboratories, academic research institutes, and others. The academic research institutes segment generated revenue of USD XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the growing number of collaborations between key industry players and academic research institutes. However, the pharmaceutical & biotechnology companies segment is expected to grow at a highest CAGR of XX% due to the increase in the number of pharmaceutical & biotechnology companies. For instance, according to India Brand Equity Foundation, the domestic pharmaceutical industry in India includes a network of 3,000 drug companies and nearly 10,500 manufacturing units.

“North America signifies one of the largest markets of glycomics Market”

For a better understanding of the market dynamics of the glycomics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 owing to period owing to wide adoption of Glycomics tools and growing awareness among researchers regarding its application in the early detection of cancer. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of XX% during the forecast period.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Glycomics Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1Market Definitions 
1.2Objective of the Study
1.3Limitation 
1.4Stake Holders 
1.5Currency Used in Report
1.6Scope of the Global Glycomics Market Study
2.1Research Methodology for the Global Glycomics  Market
 2.1.1Main Objective of the Global Glycomics  Market
3MARKET SYNOPSIS
5COVID-19 IMPACT
6GLOBAL GLYCOMICS MARKET REVENUE
7.1Enzymes  
 7.1.1Glycosidases
 7.1.2Glycosyltransferases
 7.1.3Neuraminidases
 7.1.4Sialyltransferases
 7.1.5Others 
7.2Instruments 
 7.2.1HPLC 
 7.2.2MALDI-TOF
 7.2.3Mass Spectrometers
 7.2.4Array Systems
 7.2.5Others 
7.3Kits  
 7.3.1Glycan Labeling Kits
 7.3.2Glycan Purification Kits
 7.3.3Glycan Release Kits
 7.3.4Others 
7.4Reagents  
 7.4.1Glycoproteins
 7.4.2Monosaccharides
 7.4.3Oligosaccharides
 7.4.4Others 
7.5Others  
8.1Diagnostics 
8.2Drug Discovery & Development
8.3Others  
9.1Pharmaceutical & Biotechnology Companies
9.2Academic Research Institutes
9.3Clinical Laboratories 
9.4Others  
10.1NORTH AMERICA GLYCOMICS MARKET 
 10.1.1United States
 10.1.2Canada 
 10.1.3Rest of North America
10.2EUROPE GLYCOMICS MARKET 
 10.2.1Germany 
 10.2.2France 
 10.2.3United Kingdom
 10.2.4Spain 
 10.2.5Italy 
 10.2.6Rest of Europe
10.3ASIA PACIFIC GLYCOMICS MARKET
 10.3.1China 
 10.3.2Japan 
 10.3.3India 
 10.3.4Australia 
 10.3.5Rest of Asia Pacific
10.4REST OF THE WORLD GLYCOMICS  MARKET 
11.1Market Drivers 
11.2Market Challenges
11.3Impact Analysis
12GLYCOMICS MARKET OPPORTUNITIES
13GLYCOMICS MARKET TRENDS & INSIGHTS
14LEGAL & REGULATORY FRAMEWORK
15.1Demand Side Analysis
15.2Supply Side Analysis 
 15.2.1Top Product Launches
 15.2.2Top Business Partnerships
 15.2.3Top Merger & Acquisitions
16VALUE CHAIN ANALYSIS
17.1Porter’s Five forces analysis
 17.1.1Bargaining power of Supplier
 17.1.2Bargaining power of Buyer
 17.1.3Industry Rivalry
 17.1.4Availability of Substitute
 17.1.5Threat of new Entrants
18.1Agilent Technologies
 18.1.1Key Facts 
 18.1.2Business Description
 18.1.3Key Product/Services Offerings
 18.1.4Growth Strategy
 18.1.5SWOT Analysis
 18.1.6Key Financials
  18.1.6.1Revenue Split
  18.1.6.2Financial Overview of Agilent Technologies
 18.1.7Recent Developments
  18.1.7.1Product Launch
  18.1.7.2Partnerships
  18.1.7.3Business Expansion and Investments
  18.1.7.4Merger and Acquisition
18.2Thermo Fisher Scientific
18.3Danaher  
18.4Merck KGaA 
18.5RayBiotech 
18.6Shimadzu Corporation
18.7Takara Bio 
18.8S-BIO  
18.9New England Biolabs
18.1Waters Corporation 
19DISCLAIMER

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Glycomics Market were the three major steps undertaken to create and analyze the adoption of NGS for the different diseases across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the glycomics technology. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the glycomics market through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the glycomics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are product, application, and end-user. Further country-level analyses were conducted to evaluate the overall utilization of glycomics in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of glycomics market. Further, we conducted factor analysis using dependent and independent variables such as increasing technological advancemnts and rising R&D funding  A thorough analysis was conducted for demand and supply-side scenario considering top partnerships, merger and acquisition, business expansion, and product launches in the glycomics industry across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the glycomics market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (USD) and the utilization rate of glycomics across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the glycomics market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the glycomics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, application, and end-user of the glycomics market.

Main Objective of the Glycomics Market Study

The current & future market trends of glycomics were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of glycomics in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of product, application, and end-user
  • Define and analysis of the regulatory framework for the glycomics industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the glycomics market for the major region
  • Major regions studied in the report include North America (the United States and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India), and Rest of the World
  • Company profiles of the glycomics market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry